Literature DB >> 24962669

Independent effects of circulating glucose, insulin and NEFA on cardiac triacylglycerol accumulation and myocardial insulin resistance in a swine model.

Maria Angela Guzzardi1, Leanne Hodson, Letizia Guiducci, Elena Sanguinetti, Pietro Di Cecco, Tiziana Liistro, Cristina Vassalle, Silvia Pardini, Lucia Giorgetti, Piero A Salvadori, Silvia Burchielli, Patricia Iozzo.   

Abstract

AIMS/HYPOTHESIS: Cardiac steatosis and myocardial insulin resistance elevate the risk of cardiac complications in obesity and diabetes. We aimed to disentangle the effects of circulating glucose, insulin and NEFA on myocardial triacylglycerol (TG) content and myocardial glucose uptake.
METHODS: Twenty-two pigs were stratified according to four protocols: low NEFA + low insulin (nicotinic acid), high NEFA + low insulin (fasting) and high insulin + low NEFA ± high glucose (hyperinsulinaemia-hyperglycaemia or hyperinsulinaemia-euglycaemia). Positron emission tomography, [U-(13)C]palmitate enrichment techniques and tissue biopsies were used to assess myocardial metabolism. Heart rate and rate-pressure product (RPP) were monitored.
RESULTS: Myocardial glucose extraction was increased by NEFA suppression and was similar in the hyperinsulinaemia-hypergylcaemia, hyperinsulinaemia-euglycaemia and nicotinic acid groups. Hyperglycaemia enhanced myocardial glucose uptake due to a mass action. Myocardial TG content was greatest in the fasting group, whereas hyperinsulinaemia had a mild effect. Heart rate and RPP increased in hyperinsulinaemia-euglycaemia, in which cardiac glycogen content was reduced. Heart rate correlated with myocardial TG and glycogen content. CONCLUSIONS/
INTERPRETATION: Elevated NEFA levels represent a powerful, self-sufficient promoter of cardiac TG accumulation and are a downregulator of myocardial glucose uptake, indicating that the focus of treatment should be to 'normalise' adipose tissue function to lower the risk of cardiac TG accumulation and myocardial insulin resistance. The observation that hyperinsulinaemia and nicotinic acid led to myocardial fuel deprivation provides a potential explanation for the cardiovascular outcomes reported in recent intensive glucose-lowering and NEFA-lowering clinical trials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24962669     DOI: 10.1007/s00125-014-3307-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period.

Authors:  Alex S T Bickerton; Rachel Roberts; Barbara A Fielding; Leanne Hodson; Ellen E Blaak; Anton J M Wagenmakers; Marjorie Gilbert; Fredrik Karpe; Keith N Frayn
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

3.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.

Authors:  Mikko Kankaanpää; Hanna-Riikka Lehto; Jussi P Pärkkä; Markku Komu; Antti Viljanen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila; Riitta Parkkola; Patricia Iozzo
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

4.  18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.

Authors:  Patricia Iozzo; Amalia Gastaldelli; Mikko J Järvisalo; Jan Kiss; Ronald Borra; Emma Buzzigoli; Antti Viljanen; G Naum; Tapio Viljanen; Vesa Oikonen; Juhani Knuuti; Timo Savunen; Piero A Salvadori; Ele Ferrannini; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

5.  Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus.

Authors:  Sebastiaan Hammer; Rutger W van der Meer; Hildo J Lamb; Hans H de Boer; Jeroen J Bax; Albert de Roos; Johannes A Romijn; Johannes W A Smit
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-15       Impact factor: 4.310

6.  Free fatty acid metabolism of the human heart at rest.

Authors:  A S Most; N Brachfeld; R Gorlin; J Wahren
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

7.  Measurement of myocardial fatty acid esterification using [1-11C]palmitate and PET: comparison with direct measurements of myocardial triglyceride synthesis.

Authors:  Andrew R Coggan; Zulfia Kisrieva-Ware; Carmen S Dence; Paul Eisenbeis; Robert J Gropler; Pilar Herrero
Journal:  J Nucl Cardiol       Date:  2009-05-29       Impact factor: 5.952

8.  Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans.

Authors:  P Nuutila; M J Knuuti; M Raitakari; U Ruotsalainen; M Teräs; L M Voipio-Pulkki; M Haaparanta; O Solin; U Wegelius; H Yki-Järvinen
Journal:  Am J Physiol       Date:  1994-12

9.  Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.

Authors:  Mary Courtney Moore; Shosuke Satake; Margaret Lautz; Scott A Soleimanpour; Doss W Neal; Marta Smith; Alan D Cherrington
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

Review 10.  Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.

Authors:  Patricia Iozzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more
  4 in total

Review 1.  Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.

Authors:  Adam J Buntaine; Binita Shah; Jeffrey D Lorin; Steven P Sedlis
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

2.  Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial.

Authors:  Gian Pio Sorice; Francesca Cinti; Lucia Leccisotti; Domenico D'Amario; Margherita Lorusso; Maria Angela Guzzardi; Teresa Mezza; Camilla Cocchi; Umberto Capece; Pietro Manuel Ferraro; Filippo Crea; Alessandro Giordano; Patricia Iozzo; Andrea Giaccari
Journal:  Diabetes Ther       Date:  2021-05-26       Impact factor: 2.945

3.  Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.

Authors:  Peter Wolf; Yvonne Winhofer; Sabina Smajis; Draženka Jankovic; Christian-Heinz Anderwald; Siegfried Trattnig; Anton Luger; Michael Krebs; Martin Krššák
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

4.  Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?

Authors:  Peter R T Bowman; Godfrey L Smith; Gwyn W Gould
Journal:  PeerJ       Date:  2021-05-25       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.